epigallocatechin gallate has been researched along with losartan potassium in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kashiwakura, I; Monzen, S | 1 |
| Chang, PC; Chen, JH; Lai, SW; Lin, C; Lin, HY; Liu, YS; Lu, DY; Tsai, CF | 1 |
2 other study(ies) available for epigallocatechin gallate and losartan potassium
| Article | Year |
|---|---|
Radioprotective effects of (-)-epigallocatechin-3-gallate on human erythrocyte/granulocyte lineages.
Topics: Antigens, CD34; Catechin; Cell Lineage; Erythrocytes; Erythropoietin; Female; Granulocyte Colony-Stimulating Factor; Granulocytes; Hematopoietic Stem Cells; Humans; Placenta; Pregnancy; Radiation-Protective Agents; Recombinant Proteins; Stem Cells; Umbilical Cord; X-Rays | 2012 |
Regulatory Effects of Neuroinflammatory Responses Through Brain-Derived Neurotrophic Factor Signaling in Microglial Cells.
Topics: Animals; Anti-Inflammatory Agents; Astrocytes; Brain-Derived Neurotrophic Factor; Catechin; Cell Line; Culture Media, Conditioned; Cyclooxygenase 2; Erythropoietin; Hedgehog Proteins; Humans; Inflammation; Inflammation Mediators; Lipopolysaccharides; Mice; Microglia; Minocycline; Models, Biological; Neuroprotective Agents; Signal Transduction | 2018 |